---
title: The story of developing Campath as a treatment of multiple sclerosis
description: Life experience of drug development, with unexpected twists and turns and the interplay of drug companies, scientists and patients with multiple sclerosis
image: https://go.technologynetworks.com/hubfs/NNR%20-%20Webinar%20Sept%2010_Social-640X360.png
---

![NNR-OnDemand-MS-990x200-v2](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/TN%20Webinars/2019/Neuroscience%2010th%20September%202019/NNR-OnDemand-MS-990x200-v2.png?width=990&name=NNR-OnDemand-MS-990x200-v2.png "NNR-OnDemand-MS-990x200-v2")

# Overview

Title:

Some additional information in one line

Duration:

Some additional information in one line

Avaliable On Demand

# Register now

### TN\_WebinarSignUp\_Neuroscience\_10thSeptember2019

To view a complete list of our trusted sponsors [click here](https://www.technologynetworks.com/tn/sponsors)

Sponsored by

![2-sponsors](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/TN%20Webinars/2019/Neuroscience%2010th%20September%202019/2-sponsors.png?width=600&name=2-sponsors.png "2-sponsors")

# Webinar Summary

The autoimmune disease multiple sclerosis (MS) targets the protective myelin sheath that coats axons in the central nervous system. MS can cause lifelong disability, and strike early in life, meaning developing effective therapies has been a primary aim of research.

 Professor Alasdair Coles has been involved in the development of drugs to treat MS for over twenty years. His work with Alastair Compston was instrumental in the identification of Campath (Alemtuzumab), a humanized monoclonal antibody, as an effective treatment for MS.

 In this webinar, Professor Coles will outline the history of Campath’s development, exploring how drug companies, scientists and patients all play a role in the success of pharmacological treatment.

**Attend this webinar to hear:

**- How antibody-based compounds have revolutionized treatment of MS
- The latest exciting developments in MS therapeutics
- The inside story of how antibodies are developed into effective therapies for brain diseases****

****# Speaker Information:

![Alasdair Coles](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/TN%20Webinars/2019/Neuroscience%2010th%20September%202019/WebinarSpeakerImage.png?width=100&name=WebinarSpeakerImage.png "Alasdair Coles")

**Alasdair Coles**  
Professor Neuroimmunology  
 University of Cambridge****

****Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)

Technology Networks Limited

Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK

[Email: privacy@technologynetworks.com](mailto:privacy@technologynetworks.com?Subject=Privacy)

 

© 2020 Technology Networks

All rights reserved

[Privacy Policy & Disclaimer](https://www.technologynetworks.com/tn/privacy)****